Definitive Contract 75N91018C00032
Award Date 9/17/18
Potential Completion Date 9/19/19
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, KS 66047, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Pointcare Genomics Corp, a small minority-owned business, for research and development in biomedical basic research. The contract is a definitive, firm-fixed price contract valued at $299,961.00 and is part of the SBIR (Small Business Innovation Research) Program Phase I. The contract has a total small business set-aside designation and was awarded on September 22, 2015, with a completion date of...
- This is a $299,999.00 definitive contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Electronic Biosciences, Inc., a small business. The contract is for the ALTERNATING-SEQ (MOONSHOT) requirement, which has a firm fixed price pricing structure and a completion date of March 16, 2020. Electronic Biosciences has prior experience providing goods and services such as nanopore platforms, temperature-controlled systems,...
- <p>This is a federal contract awarded by the National Cancer Institute, a civilian agency, to Transgenex Nanobiotech Inc., a minority-owned small business. The contract, valued at $224,999.00, is for a Small Business Innovation Research (SBIR) Program Phase I action. The contract is a definitive, firm-fixed-price contract with a completion date of September 15, 2015. This contract is set aside for small businesses.</p>
- <p>The U.S. Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I firm-fixed-price contract to Mediomics LLC, a woman-owned small business, to develop novel tools for site-specific quantitative analysis of RNA modifications. The contract has a potential value of $248,357.00 and a completion date of June 18, 2018.</p>
- This is a $1,698,988.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS), to Insight Genetics, Inc., a small business. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a total small business set-aside designation. The contract was awarded on September 20, 2012 and has an ultimate completion date of August 16, 2015. This contract award is not associated...
- This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a "CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM" under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...
- This is a $273,600 firm-fixed-price definitive contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to JBS Science Inc., a small business biotechnology company. The contract is for the development of a cell-free circulating DNA-based assay for liver cancer screening. This award supports NCI's efforts to advance innovative molecular diagnostic technologies for cancer detection and monitoring. As a small business set-aside contract, the...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nvigen, Inc., a small disadvantaged business and woman-owned manufacturer. The contract is for the development of cell-free tumor DNA (ctDNA) diagnostic enabled by magnetic automation assays, under SBIR Topic 353. The contract has a firm fixed price of $275,261.00 and a completion date of August 18, 2017. The contract does not utilize a set-aside...